Cargando…

Budget impact analysis of anakinra in the treatment of familial Mediterranean fever in Italy

Introduction: Familial Mediterranean Fever (FMF) is a hereditary autoinflammatory disease that significantly reduces occupational productivity and quality-of-life in affected patients. Italy has an estimated FMF prevalence of 1 in 60,000 people. While colchicine is the primary treatment for FMF, bio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aiello, A, Mariano, EE, Prada, M, Cioni, L, Teruzzi, C, Manna, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Routledge 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930828/ https://www.ncbi.nlm.nih.gov/pubmed/36819891 http://dx.doi.org/10.1080/20016689.2023.2176091

Ejemplares similares

Budget impact analysis for avatrombopag in the treatment of chronic primary immune thrombocytopenia in adult patients refractory to other treatments
por: Aiello, Andrea, et al.
Publicado: (2023)

The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever
por: Calligaris, Lorenzo, et al.
Publicado: (2007)

Anakinra treatment in patients with Familial Mediterranean Fever: a single-center experience
por: Ugurlu, S, et al.
Publicado: (2015)

Ulcerative Colitis and Familial Mediterranean Fever: Can Anakinra Treat Both?
por: Kaly, Lisa, et al.
Publicado: (2019)

Erratum in: Budget Impact Analysis of anakinra in the treatment of patients with Still’s Disease
por: Ravasio, Roberto, et al.
Publicado: (2020)

Colchicine-resistant familial Mediterranean fever in a renal transplantation patient: successful treatment with anakinra
por: Celebi, Zeynep Kendi, et al.
Publicado: (2014)

Familial mediterranean fever and pauciimmune renal vasculitis: the role of IL-1 blockade (Anakinra)
por: Lovillo, MS Camacho, et al.
Publicado: (2011)

Cost analysis of extended half-life recombinant factor IX products in the treatment of haemophilia B in Italy: an update
por: Aiello, Andrea, et al.
Publicado: (2022)

Budget impact analysis of extended half-life recombinant factor IX (rFIXFc) in the treatment of haemophilia B
por: Aiello, Andrea, et al.
Publicado: (2020)

Corticosteroid-resistant anakinra-responsive protracted febrile myalgia syndrome as the first manifestation of familial Mediterranean fever
por: Cakan, Mustafa, et al.
Publicado: (2019)

Familial Mediterranean Fever: Assessing the Overall Clinical Impact and Formulating Treatment Plans
por: Manna, Raffaele, et al.
Publicado: (2019)

Analisi di budget impact di anakinra nel trattamento della Malattia di Still in Italia
por: Ravasio, Roberto, et al.
Publicado: (2020)

Anakinra for Recurrent Fevers in Systemic Lupus Erythematosus
por: Dein, Eric, et al.
Publicado: (2018)

Familial Mediterranean Fever without Fever
por: Hotta, Yuma, et al.
Publicado: (2020)

P03-019 - Anakinra for sweet syndrome treatment
por: Passaro, G, et al.
Publicado: (2013)

Familial Mediterranean fever; diagnosis, treatment, and complications
por: Bashardoust, Bahman
Publicado: (2015)

Familial Mediterranean Fever and Hypercoagulability
por: Tayer-Shifman, Oshrat E., et al.
Publicado: (2011)

An Update on Familial Mediterranean Fever
por: Lancieri, Maddalena, et al.
Publicado: (2023)

Analysis of microRNAs in familial Mediterranean fever
por: Amarilyo, Gil, et al.
Publicado: (2018)

Acamprosate in the treatment of alcoholism: a budget impact analysis for the National Health Service in Italy
por: Colombo, Giorgio L, et al.
Publicado: (2012)

Medical Cannabis in Treatment of Resistant Familial Mediterranean Fever
por: Habib, George, et al.
Publicado: (2019)

Economic impact of juvenile idiopathic arthritis and familial Mediterranean fever
por: Yucel, Ilker Kemal, et al.
Publicado: (2011)

Chronic Autoimmune Meningoencephalitis and Periodic Fever Syndrome Treated with Anakinra
por: Novroski, Alyssa-Rae, et al.
Publicado: (2017)

Protocol Implementation for Normothermia in Surgery Settings in Italy: Budget-Impact Analysis
por: Monzani, Roberta, et al.
Publicado: (2020)

Familial Mediterranean Fever in older children
por: Özdel, Semanur, et al.
Publicado: (2014)

The role of genotype in Familial Mediterranean Fever
por: Özdel, Semanur, et al.
Publicado: (2014)

Familial Mediterranean fever: current perspectives
por: Sönmez, Hafize Emine, et al.
Publicado: (2016)

Comorbidities in patients with Familial Mediterranean Fever
por: Balci-Peynircioğlu, B, et al.
Publicado: (2015)

Neonatal onset Familial Mediterranean Fever
por: Özçakar, ZB, et al.
Publicado: (2015)

Cardiac manifestations of Familial Mediterranean fever
por: Alsarah, Ahmad, et al.
Publicado: (2017)

Vascular risk in familial Mediterranean fever
por: Rodríguez, Alexander J.
Publicado: (2017)

Association of Vasculitis and Familial Mediterranean Fever
por: Abbara, Salam, et al.
Publicado: (2019)

Posterior Scleritis in Familial Mediterranean Fever
por: Mansour, Ahmad M., et al.
Publicado: (2019)

Neurological Face of Familial Mediterranean Fever
por: Bektaş, Polat Cengiz, et al.
Publicado: (2022)

Small Intestinal Bacterial Overgrowth Affects the Responsiveness to Colchicine in Familial Mediterranean Fever
por: Verrecchia, E., et al.
Publicado: (2017)

Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy
por: Cortesi, Paolo Angelo, et al.
Publicado: (2022)

Rickettsia monacensis as Cause of Mediterranean Spotted Fever–like Illness, Italy
por: Madeddu, Giordano, et al.
Publicado: (2012)

Mesothelioma in Familial Mediterranean Fever With Colchicine Intolerance: A Case Report and Literature Review
por: Talerico, Rosa, et al.
Publicado: (2020)

The impact of COVID-19 on familial Mediterranean fever: a nationwide study
por: Günendi, Zafer, et al.
Publicado: (2021)

Anakinra in Paediatric Rheumatology and Periodic Fever Clinics: Is the Higher Dose Safe?
por: Fingerhutová, Šárka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ip4urnghqsncutbvis5d9tsst3